home.social

#pharmachallenges โ€” Public Fediverse posts

Live and recent posts from across the Fediverse tagged #pharmachallenges, aggregated by home.social.

  1. ๐—ช๐—ต๐—ฎ๐˜โ€™๐˜€ ๐˜๐—ต๐—ฒ ๐—ฏ๐—ถ๐—ด๐—ด๐—ฒ๐˜€๐˜ ๐—ฏ๐—ผ๐˜๐˜๐—น๐—ฒ๐—ป๐—ฒ๐—ฐ๐—ธ ๐—ถ๐—ป ๐—ฏ๐—ถ๐—ผ๐—ฝ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ ๐—ฒ๐˜…๐—ฝ๐—ฎ๐—ป๐˜€๐—ถ๐—ผ๐—ป?
    Despite growth, challenges like high ๐—บ๐—ฎ๐—ป๐˜‚๐—ณ๐—ฎ๐—ฐ๐˜๐˜‚๐—ฟ๐—ถ๐—ป๐—ด ๐—ฐ๐—ผ๐˜€๐˜๐˜€ ๐—ฎ๐—ป๐—ฑ ๐—ฐ๐—ผ๐—บ๐—ฝ๐—น๐—ฒ๐˜… ๐—ฎ๐—ฝ๐—ฝ๐—ฟ๐—ผ๐˜ƒ๐—ฎ๐—น ๐˜๐—ถ๐—บ๐—ฒ๐—น๐—ถ๐—ป๐—ฒ๐˜€ continue to slow market scalability.
    ๐—ฅ๐—ฒ๐—ฎ๐—ฑ ๐—บ๐—ผ๐—ฟ๐—ฒ: kenresearch.com/industry-repor

    #PharmaChallenges #DrugApproval #Biotech #HealthcareIndustry